Copyright
©The Author(s) 2015.
World J Cardiol. Jul 26, 2015; 7(7): 392-396
Published online Jul 26, 2015. doi: 10.4330/wjc.v7.i7.392
Published online Jul 26, 2015. doi: 10.4330/wjc.v7.i7.392
Ref. | Study design | No. of patients | Mean age(yr) | Male gender | NYHA class | EF | Renal function | Main findings | Comment |
Koch et al[11] | Prospective | 118 | 73.2 | 60.2% | III (49.2%) | 43.5% | Creatinine clearance 19.2 mL/min | Significant improvement in body | Negligible incidence of peritonitis and catheter dysfunction |
IV (50.8%) | Weight and NYHA class | ||||||||
Núñez et al[8] | Prospective | 25 | 75.1 | 72% | III or IV (100%) | 40% | eGFR 33 mL/min per 1.73 m2 | Significant improvement in patients’ clinical status and NYHA class | Marked reduction in the number of days hospitalized for acute heart failure |
Bertoli et al[12] | Multicenter retrospective | 48 | 74 | 81% | II (6%) | 30% | eGFR 21 mL/min per 1.73 m2 | Significant improvement in NYHA class and reduction in the number of days hospitalized | Significant reduction in pulmonary artery pressure and improvement in EF |
III (48%) | |||||||||
IV (46%) | |||||||||
Courivaud et al[10] | Retrospective | 126 | 72 | 69% | N/A | 38% | eGFR 33.5 mL/min per 1.73 m2 | Significant reduction in the number of days hospitalized for acute heart failure | Improvement in cardiac function in patients with a an EF of 30% or less |
- Citation: Kazory A. Peritoneal dialysis for chronic cardiorenal syndrome: Lessons learned from ultrafiltration trials. World J Cardiol 2015; 7(7): 392-396
- URL: https://www.wjgnet.com/1949-8462/full/v7/i7/392.htm
- DOI: https://dx.doi.org/10.4330/wjc.v7.i7.392